Daniel Kisner Insider Profile

4 Followers
Daniel Kisner, Director at Dynavax, holds 17.57K shares in Dynavax (Ticker: DVAX), holds 0.00 shares in Zynerba Pharmaceuticals (Ticker: ZYNE), holds 10.00K shares in Oncternal Therapeutics (Ticker: ONCT).
tipranks
Daniel Kisner

Daniel Kisner
Dynavax (DVAX)
Director

Ranked #43,508 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+10.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$296K
80.04%
15.35%
4.08%
0.52%
A breakdown of Daniel Kisner's holdings

Insider Roles

Dynavax
(DVAX)
Director
Arbutus Biopharma
(ABUS)
Former Director
Oncternal Therapeutics
(ONCT)
Director
Histogen
(HSTO)
Director
Roles that Daniel Kisner holds in companies

Most Profitable Insider Trade

Stock:
Oncternal Therapeutics
(ONCT)
Rating:Informative Buy
Date:Jul 23, 2020 - Jul 23, 2021
Return:+68.00%
The most profitable trade made by Daniel Kisner

Daniel Kisner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dynavax
May 28, 2024
Director
Uninformative Buy
$237.21K
ZYNE
Zynerba Pharmaceuticals
Oct 11, 2023
Uninformative Sell
$0.00
Oncternal Therapeutics
Jul 23, 2020
Director
Informative Buy
23.80K
$12.10K
Arbutus Biopharma
Dec 31, 2014
Former Director
Uninformative Buy
$45.50K
Histogen
Dec 30, 2016
Director
Uninformative Buy
$1.54K
APEN
Apollo Endosurgery
Jul 31, 2012
Uninformative Buy
$705.90K
List of latest transactions for each holding click on a transaction to see Daniel Kisner's performance on stock

Daniel Kisner insider profile FAQ

What is the percentage of profitable transactions made by Daniel Kisner?
The percentage of profitable transactions made by Daniel Kisner is 50%.
    What is the average return per transaction made by Daniel Kisner?
    The average return per transaction made by Daniel Kisner is 10.10%.
      What stocks does Daniel Kisner hold?
      Daniel Kisner holds: DVAX, ZYNE, ONCT, ABUS, HSTO, APEN stocks.
        What was Daniel Kisner’s latest transaction?
        Daniel Kisner latest transaction was an Uninformative Buy of ―.
          What was Daniel Kisner's most profitable transaction?
          Daniel Kisner’s most profitable transaction was an Informative Buy of ONCT stock on July 23, 2020. The return on the trade was 68.00%.
            What is Daniel Kisner's role in Dynavax?
            Daniel Kisner's role in Dynavax is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.